J. Hilfenhaus

1.3k total citations
71 papers, 965 citations indexed

About

J. Hilfenhaus is a scholar working on Epidemiology, Immunology and Genetics. According to data from OpenAlex, J. Hilfenhaus has authored 71 papers receiving a total of 965 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 21 papers in Immunology and 18 papers in Genetics. Recurrent topics in J. Hilfenhaus's work include Virus-based gene therapy research (17 papers), Herpesvirus Infections and Treatments (14 papers) and Cytomegalovirus and herpesvirus research (9 papers). J. Hilfenhaus is often cited by papers focused on Virus-based gene therapy research (17 papers), Herpesvirus Infections and Treatments (14 papers) and Cytomegalovirus and herpesvirus research (9 papers). J. Hilfenhaus collaborates with scholars based in Germany, United States and United Kingdom. J. Hilfenhaus's co-authors include Holger Kirchner, Rainer Zawatzky, E. Weinmann, Hermann Erich Karges, Eckhart Weidmann, T Nowak, U. Klockmann, Fabrizio Marcucci, Hans Moser and Thomas Nowak and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

J. Hilfenhaus

70 papers receiving 827 citations

Peers

Countries citing papers authored by J. Hilfenhaus

Since Specialization

Citations

This map shows the geographic impact of J. Hilfenhaus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Hilfenhaus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Hilfenhaus more than expected).

Fields of papers citing papers by J. Hilfenhaus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Hilfenhaus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Hilfenhaus. The network helps show where J. Hilfenhaus may publish in the future.

Co-authorship network of co-authors of J. Hilfenhaus

This figure shows the co-authorship network connecting the top 25 collaborators of J. Hilfenhaus. A scholar is included among the top collaborators of J. Hilfenhaus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Hilfenhaus. J. Hilfenhaus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Analysis of human plasma products: polymerase chain reaction does not discriminate between live and inactivated viruses 1997 ·Transfusion ·J. Hilfenhaus, Albrecht Gröner, T Nowak, Thomas Weimer	32
2	EPFA – NIBSC Workshop on ‘Nucleic Acid Amplification Assays and Plasma Products’ 1995 ·Biologicals ·W.P. Zeijlemaker, H. Theo M. Cuijpers, W.G. van Aken, J. Saldanha, Michael P. Busch, Giuseppe Colucci, (unknown), J. Hilfenhaus, Bernard Horowitz, H. O. Kangro, (unknown), P.N. Lelie, Peter Lens, Johannes Löwer, James S. Robertson, G. C. Schild, Peter Simmonds, P.L. Yap	2
3	Inactivation of Hepatitis A Virus by Pasteurization and Elimination of Picornaviruses during Manufacture of Factor VIII Concentrate 1994 ·Vox Sanguinis ·J. Hilfenhaus, T Nowak	13
4	Theoretical and technical concerns in inactivation/elimination of viruses in plasma derivatives. 1993 ·PubMed ·J. Hilfenhaus, Matthias Niedrig, T Nowak	2
5	Immune response of chimpanzees after immunization with the inactivated whole immunodeficiency virus (HIV-1), three different adjuvants and challenge 1993 ·Vaccine ·Matthias Niedrig, (unknown), Patricia N. Fultz, Michael Bröker, (unknown), J. Hilfenhaus	17
6	Inactivation of viruses related to hepatitis C virus by pasteurization in human plasma derivatives 1992 ·Biologicals ·Thomas Nowak, (unknown), J. Hilfenhaus	8
7	Virus safety of human immunoglobulins: Efficient inactivation of hepatitis C and other human pathogenic viruses by the manufacturing procedure 1992 ·Journal of Medical Virology ·Thomas Nowak, Jens‐Peter Gregersen, U. Klockmann, Larry B. Cummins, J. Hilfenhaus	25
8	Follow-up of hepatitis C virus infection in chimpanzees: determination of viraemia and specific humoral immune response 1992 ·Journal of General Virology ·J. Hilfenhaus, (unknown), T Nowak, Larry B. Cummins, Klaus Fuchs, M Roggendorf	25
9	A Rabies-Specific Human Monoclonal Antibody That Protects Mice Against Lethal Rabies 1991 ·Hybridoma ·Karlheinz Enssle, R. Kurrle, (unknown), (unknown), E. J. Kanzy, J. Hilfenhaus, F. R. Seiler	26
10	Inactivation of retroviruses in biologicals manufactured for human use. 1991 ·PubMed ·J. Hilfenhaus, (unknown), Helena Müller-Kräuter, T Nowak, (unknown)	3
11	Escherichia coli-derived envelope protein gD but not gC antigens of herpes simplex virus protect mice against a lethal challenge with HSV-1 and HSV-2 1990 ·Medical Microbiology and Immunology ·Michael Bröker, (unknown), (unknown), J. Hilfenhaus, Egon Amann	8
12	Antibody‐ and complement‐mediated lysis of HIV‐infected cells and inhibition of viral replication 1990 ·Journal of Medical Virology ·(unknown), (unknown), Andreas S. Baur, J. Hilfenhaus	18
13	Heat inactivation of human immunodeficiency virus type 2 (HIV-2) 1989 ·Journal of Biological Standardization ·(unknown), J. Hilfenhaus, (unknown)	7
14	Preclinical investigations of the safety, immunogenicity and efficacy of a purified, inactivated tick-borne encephalitis vaccine 1989 ·Journal of Biological Standardization ·U. Klockmann, H.L. Bock, (unknown), (unknown), (unknown), J. Hilfenhaus	29
15	Fibrin glue safety: inactivation of potential viral contaminants by pasteurization of the human plasma components. 1985 ·PubMed ·J. Hilfenhaus, Eckhart Weidmann	32
16	Pharmacokinetics of Human Interferon-Beta in Monkeys 1981 ·Journal of Interferon Research ·J. Hilfenhaus, (unknown), (unknown), (unknown), H. Ronneberger, E. Weinmann	21
17	HUMAN FIBROBLAST AND HUMAN LEUKOCYTE INTERFERON: THEIR DIFFERENCES IN CELL GROWTH INHIBITION ACTIVITIES ON LYMPHOBLASTOID CELLS 1980 ·Annals of the New York Academy of Sciences ·J. Hilfenhaus, (unknown)	3
18	A purified human diploid cell rabies vaccine. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·(unknown), J. Hilfenhaus, (unknown), (unknown), W. Hennessen	4
19	Zonal-centrifuged human diploid cell rabies vaccine. 1976 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·(unknown), J. Hilfenhaus, (unknown), W. Hennessen	2
20	Notizen: Requirement of Cellular RNA-synthesis for the Inhibition of Semliki Forest Virus by poly (rI) · poly (rC) 1972 ·Zeitschrift für Naturforschung B ·J. Hilfenhaus, (unknown), C. Jungwirth	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact